The National Comprehensive Cancer Network (NCCN) guidelines for genetic assessment in hereditary breast cancer (version 3.2019) recommends genetic evaluation of ATM, CDH1, CHEK2, NBN, NF1, and PALB2 in addition to BRCA1/2 genes. This evidence concerns the gene CHEK2 and breast carcinoma.